Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS

被引:1
|
作者
Jin, Xiu [1 ]
Liu, Feifei [1 ]
Zhang, Ya [2 ]
Ma, Yingying [3 ]
Yang, Linqing [3 ]
Wang, Yunfei [3 ]
Liu, Ying [3 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Pathol, Jining, Shandong, Peoples R China
[2] Jining Med Univ, Affiliated Hosp, Dept Obstet, Jining, Shandong, Peoples R China
[3] Jining Med Univ, Dept Gynecol, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
Cervical cancer; ASCUS; HPV E6/E7 mRNA; Menopause; Colposcope; CERVICAL-CANCER; PREVENTION; WOMEN; PERFORMANCE; POPULATION; LESIONS;
D O I
10.1186/s12905-023-02599-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy pathological results to provide a more accurate basis for managing ASCUS patients.Methods A total of 1387 patients with ASCUS and HPV E6/E7 mRNA positivity who were referred for colposcopy were retrospectively analyzed. They were divided into HPV16+, 18/45 + and other HR-HPV + groups premenopausal and postmenopausal groups. The pathological results of the biopsy were divided into the LSIL- group (including normal and low-grade squamous intraepithelial lesions) and the HSIL + group (including high-grade squamous intraepithelial lesions and higher lesions). SPSS was used for the analysis.Results The age group 31-40 years had the highest level of HPV16+, and HPV18/45 + was the highest in the 41-50 years group. The detection rates of HSIL + in the HPV16+, HPV18/45+, HPV 16/18/45 + and Other HR-HPV + groups were 48.4%, 18.8%, 43.9% and 15.0%, respectively. The infection rates of HPV16/18/45 in postmenopausal and premenopausal women were 42.4% and 34.3%, respectively. In the HPV18/45 group, the incidence of HSIL + was 30.0% in postmenopausal women and 15.0% in premenopausal women (P < 0.01). In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. The incidence of cervical cancer in postmenopausal patients is significantly higher than that in premenopausal patients.Conclusions Colposcopy referral or further biopsy is recommended for all ASCUS patients with HPV16/18/45E6/E7 mRNA positivity and postmenopausal patients with HR-HPVE6/E7 mRNA positivity. For premenopausal ASCUS patients with other HR-HPV E6/E7 mRNA positivity, colposcopy should be performed if possible, depending on the specific situation, to achieve early detection and diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
    Xiu Jin
    Feifei Liu
    Ya Zhang
    Yingying Ma
    Linqing Yang
    Yunfei Wang
    Ying Liu
    BMC Women's Health, 23
  • [2] Shunt value of HPV E6/E7 mRNA examination in damp-heat type ASCUS
    Shi, Yun-Xuan
    Yin, Yan-Qing
    Zhang, Shuai
    MINERVA MEDICA, 2023,
  • [3] High-risk HPV E6/E7 mRNA in situ expression in cervical premalignant lesions
    Benedetti, I.
    Barrios, L.
    Rodriguez, R.
    VIRCHOWS ARCHIV, 2024, 485 : S83 - S84
  • [4] E6/E7 mRNA Expression of High-risk HPV Types in 849 Greek Women
    Argyri, Elena
    Tsimplaki, Elpida
    Daskalopoulou, Dimitra
    Stravopodis, Dimitrios J.
    Kouikoglou, Ourania
    Terzakis, Emmanouil
    Panotopoulou, Efstathia
    ANTICANCER RESEARCH, 2013, 33 (09) : 4007 - 4011
  • [5] THE CARCINOGENIC POTENTIAL OF E6 & E7 GENES OF HIGH-RISK HPV COMPARED WITH E6, E7 GENES OF LOW-RISK HPV IN HUMAN CERVICAL CANCER: A REVIEW
    Gill, Sher Singh
    Jana, A. M.
    Shrivastav, Archana
    Sharma, Sachin
    Sharma, Arvind
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (03): : 703 - 712
  • [6] A Comparative Evaluation of HPV OncoTect E6 E7 mRNA and Cervista HPV 16/18 Tests on High-Risk HPV Samples
    Noy, M. A.
    Paz, J. R.
    Rosado, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 872 - 873
  • [7] Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
    Ying Liu
    Xiu Jin
    Yingying Gong
    Yingying Ma
    Beibei Du
    Linqing Yang
    Yunfei Wang
    Weipei Zhu
    Infectious Agents and Cancer, 18
  • [8] Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
    Liu, Ying
    Jin, Xiu
    Gong, Yingying
    Ma, Yingying
    Du, Beibei
    Yang, Linqing
    Wang, Yunfei
    Zhu, Weipei
    INFECTIOUS AGENTS AND CANCER, 2023, 18 (01)
  • [9] In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer
    Randen-Brady, Reija
    Carpen, Timo
    Jouhi, Lauri
    Syrjanen, Stina
    Haglund, Caj
    Tarkkanen, Jussi
    Remes, Satu
    Makitie, Antti
    Mattila, Petri S.
    Silen, Suvi
    Hagstrom, Jaana
    HUMAN PATHOLOGY, 2019, 90 : 97 - 105
  • [10] HPV E6/E7 mRNA检测对ASCUS患者临床分层处理价值评价
    朱远航
    任琛琛
    张小安
    崔世红
    杨立
    刘灵
    实用妇产科杂志, 2017, 33 (08) : 595 - 598